Medical Studies*

Therapy to Increase Sexual Function, and Decrease Intercourse Pain

This was our third clinical study to be published in a major international medical journal (the first publication being a dual study). The study was conducted after several women reported unexpected improved sexual function, following therapy. In short, they reported "side effects" of significantly increased orgasm intensity and desire when they returned home after therapy.

We were encouraged to conduct this study by Richard King, MD, former Chief of Staff of our local hospital. Dr. King felt this was an area worthy of investigation, as up to 40% of all women suffer some type of sexual dysfunction.

The study examines changes in sexual function in the six areas of that can be measured by scientists. These are: desire, arousal, lubrication, orgasm, satisfaction and pain. The study found significant improvements in all six areas.

This study was published by Medscape General Medicine in December, 2004 and is now a Medline searchable part of the US National Library of Medicine.

published abstract

Medscape General Medicine™
Medscape General Medicine Ob/Gyn & Women's Health
Medscape General Medicine, © 2004 Medscape Published 12/14/2004

Increasing Orgasm and Decreasing Dyspareunia (Intercourse Pain) by a Manual Physical Therapy Technique*
Published 12/14/2004

Lawrence J. Wurn, LMT; Belinda F. Wurn, PT; C. Richard King, MD; Amanda S. Roscow, MPT; Eugenia S. Scharf, PhD; Jonathan J. Shuster, PhD

Abstract

Objective: To evaluate the effectiveness of a new site-specific, manual soft-tissue therapy in increasing orgasm and reducing dyspareunia (painful intercourse) in women with histories indicating abdominopelvic adhesion formation.

Design and Intervention: A total of 29 new patients presenting with infertility or abdominopelvic pain-related problems, and also indicating sexual pain or dysfunction, received a series of treatments (mean, 19.5 hours) designed to address biomechanical dysfunction and restricted mobility due to adhesions affecting the reproductive organs and adjacent structures.

Outcome Measures: Primary outcome measures were post-test vs pretest scores on: (1) the Female Sexual Function Index (FSFI) full scale, orgasm domain, and pain domain; and (2) 3 supplemental 10-point rating scales of sexual pain levels. Secondary outcome measures were post-test vs pretest scores in the other 4 FSFI domains (desire, arousal, lubrication, and satisfaction). The Wilcoxon signed-rank test was used for all statistical analyses.

Results: For the 23 patients available for follow-up, the paired FSFI post-test vs. pretest scores were significant (P </= .003) on all measures. Of the 17 patients who completed the 3 sexual pain scales, the paired post-test vs. pretest scores were significant (P </= .002)

Conclusions: Many cases of inhibited orgasm, dyspareunia, and other aspects of sexual dysfunction seem to be treatable by a distinctive, noninvasive manual therapy with no risks and few, if any, adverse effects. The therapy should be considered a new adjunct to existing gynecologic and medical treatments.

* Wurn Technique, patent pending

Complete published study available courtesy of PubMed, a service of the National Library of Medicine and the National Institutes of Health.